Samuel Rollins Email

VP, Legal . Beam Therapeutics

Current Roles

Employees:
549
Revenue:
$67.7M
About
Beam Therapeutics is developing precision genetic medicines for serious diseases. Co-founded by scientific pioneers known for advancing CRISPR gene editing, were the first company to pursue development of new therapies using CRISPR base editing technology. We aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. WHO WE ARE Beam is creating precision genetic medicines through base editing WHY WE DO IT Our dream is to provide life-long cures for patients suffering from serious diseases WHO WE ARE AND HOW WE WORK TOGETHER The Beam Team: A community of fearless innovators Rigorous and honest in our research Listening with open minds Committed to each other
Beam Therapeutics Address
238 Main Street
Cambridge, MA
United States
Beam Therapeutics Email

Past Companies

Beam TherapeuticsVP, Legal
vTv Therapeutics LLCSVP, Intellectual Property
TransTech PharmaVice President, Intellectual Property

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.